Carmen Terán

Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors

María João Matos, Carmen Terán, Yunierkis Pérez‐Castillo et al. · Journal of Medicinal Chemistry · 2011 · 165 citations · Full text

ANN-QSAR model for selection of anticancer leads from structurally heterogeneous series of compounds

Humberto González‐Díaz, Isis Bonet, Carmen Terán et al. · European Journal of Medicinal Chemistry · 2006 · 72 citations

Combinatorial Chemistry, Medicinal Chemistry, Natural Sciences +10

New pyridazinone derivatives with vasorelaxant and platelet antiaggregatory activities

Tamara Costas, Pedro Besada, Alessandro Piras et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 56 citations

Medicinal Chemistry, Blood Platelet, Medicine +6

Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors

María Carmen Costas-Lago, Pedro Besada, Fernanda Rodríguez‐Enríquez et al. · European Journal of Medicinal Chemistry · 2017 · 51 citations · Full text

Medicinal Chemistry, Medicine, Natural Sciences +11

Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson’s disease therapy

Fernanda Rodríguez‐Enríquez, María Carmen Costas-Lago, Pedro Besada et al. · Bioorganic Chemistry · 2020 · 51 citations · Full text

Molecular Pharmacology, Medicine, Psychotropic Medication +7